As the alternative protein industry matures, which product type, innovation, and investment trends will take the stage in 2022? GFI’s experts predict what’s next.
If you’re interested in the rapidly expanding sector for emerging proteins, or are already part of the ecosystem in Australia and New Zealand, AltProteins 22 will provide you with valuable knowledge-sharing, problem-solving and collaborative opportunities.
The manufacturing capacity for rapid and cost-effective scale-up of alternative protein production is a current constraint on the growth of the industry. Repurposing and retrofitting stranded or underutilized assets such as shuttered bioethanol plants can help mitigate some of the financial hurdles and shorten the amount of time required for companies to expand production.
- Bioprocess design
- Business Services
- End product formulation & manufacturing
- Raw Materials, Ingredients, & Inputs
A fair and sensible regulatory framework is necessary to bring cultivated meat and poultry to market and prevent consumer confusion.
GFI submitted comments in response to the USDA’s Advanced Notice of Proposed Rulemaking (ANPR) regarding cultivated meat labeling. GFI advocates for a clear, practical, and flexible regulatory pathway to market for these products and recommends that USDA-FSIS create a regulatory framework that treats cultivated products and conventional products fairly and equally.
Good Food Institute calls on Virginia’s governor to reject unconstitutional “milk” label censorship bill
In a press release calling on Virginia's governor to veto a milk label censorship bill, Emily notes that, “in addition to being unconstitutional, this bill is redundant and unnecessary,” creating undo communication barriers between companies and consumers.
To the Office of Science and Technology Policy on creating an interagency research initiative on alternative proteins
GFI’s comment recommends that President Biden’s Administration form a federal interagency research initiative coordinated by the Office of Science and Technology Policy to support open-access alternative protein research and development.